1. Home
  2. CEVA vs PAHC Comparison

CEVA vs PAHC Comparison

Compare CEVA & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEVA Inc.

CEVA

CEVA Inc.

HOLD

Current Price

$36.22

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$34.10

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEVA
PAHC
Founded
1999
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CEVA
PAHC
Price
$36.22
$34.10
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$30.33
$41.25
AVG Volume (30 Days)
636.9K
270.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
0.91%
EPS Growth
N/A
1883.33
EPS
N/A
1.90
Revenue
$87,507,000.00
$833,350,000.00
Revenue This Year
$12.37
$17.03
Revenue Next Year
$13.82
$3.82
P/E Ratio
N/A
$17.92
Revenue Growth
20.45
4.12
52 Week Low
$17.02
$25.58
52 Week High
$51.60
$60.08

Technical Indicators

Market Signals
Indicator
CEVA
PAHC
Relative Strength Index (RSI) 39.40 54.07
Support Level $35.61 $30.55
Resistance Level $49.89 $34.67
Average True Range (ATR) 2.64 1.25
MACD -0.77 0.28
Stochastic Oscillator 3.46 79.28

Price Performance

Historical Comparison
CEVA
PAHC

About CEVA CEVA Inc.

CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived mainly from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems. The company operates in one reportable segment: the licensing of IP to semiconductor companies and electronic equipment manufacturers.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: